Logo image of EUZ.DE

ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:EUZ - DE0005659700 - Common Stock

15.41 EUR
-0.38 (-2.41%)
Last: 1/8/2026, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to EUZ. EUZ was compared to 65 industry peers in the Health Care Equipment & Supplies industry. EUZ scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EUZ is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make EUZ a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

EUZ had positive earnings in the past year.
EUZ had a positive operating cash flow in the past year.
EUZ had positive earnings in each of the past 5 years.
Each year in the past 5 years EUZ had a positive operating cash flow.
EUZ.DE Yearly Net Income VS EBIT VS OCF VS FCFEUZ.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

EUZ has a better Return On Assets (8.79%) than 81.54% of its industry peers.
With an excellent Return On Equity value of 17.17%, EUZ belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
EUZ has a Return On Invested Capital of 12.48%. This is amongst the best in the industry. EUZ outperforms 89.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EUZ is in line with the industry average of 10.04%.
The 3 year average ROIC (9.92%) for EUZ is below the current ROIC(12.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.79%
ROE 17.17%
ROIC 12.48%
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
EUZ.DE Yearly ROA, ROE, ROICEUZ.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

EUZ has a Profit Margin of 13.06%. This is in the better half of the industry: EUZ outperforms 75.38% of its industry peers.
EUZ's Profit Margin has declined in the last couple of years.
EUZ has a better Operating Margin (21.27%) than 86.15% of its industry peers.
In the last couple of years the Operating Margin of EUZ has grown nicely.
With a Gross Margin value of 47.25%, EUZ is not doing good in the industry: 66.15% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EUZ has remained more or less at the same level.
Industry RankSector Rank
OM 21.27%
PM (TTM) 13.06%
GM 47.25%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
EUZ.DE Yearly Profit, Operating, Gross MarginsEUZ.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EUZ is creating some value.
EUZ has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, EUZ has more shares outstanding
Compared to 1 year ago, EUZ has an improved debt to assets ratio.
EUZ.DE Yearly Shares OutstandingEUZ.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EUZ.DE Yearly Total Debt VS Total AssetsEUZ.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EUZ has an Altman-Z score of 4.76. This indicates that EUZ is financially healthy and has little risk of bankruptcy at the moment.
EUZ has a Altman-Z score of 4.76. This is in the better half of the industry: EUZ outperforms 80.00% of its industry peers.
The Debt to FCF ratio of EUZ is 1.05, which is an excellent value as it means it would take EUZ, only 1.05 years of fcf income to pay off all of its debts.
EUZ has a Debt to FCF ratio of 1.05. This is amongst the best in the industry. EUZ outperforms 86.15% of its industry peers.
EUZ has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
EUZ has a Debt to Equity ratio of 0.16. This is in the better half of the industry: EUZ outperforms 70.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.05
Altman-Z 4.76
ROIC/WACC1.79
WACC6.98%
EUZ.DE Yearly LT Debt VS Equity VS FCFEUZ.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

EUZ has a Current Ratio of 2.93. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
EUZ has a better Current ratio (2.93) than 78.46% of its industry peers.
EUZ has a Quick Ratio of 2.37. This indicates that EUZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EUZ (2.37) is better than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.37
EUZ.DE Yearly Current Assets VS Current LiabilitesEUZ.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.67% over the past year.
EUZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.65% yearly.
The Revenue has grown by 9.64% in the past year. This is quite good.
The Revenue has been growing by 10.63% on average over the past years. This is quite good.
EPS 1Y (TTM)43.67%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%68.5%
Revenue 1Y (TTM)9.64%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%7.42%

3.2 Future

Based on estimates for the next years, EUZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.11% on average per year.
Based on estimates for the next years, EUZ will show a quite strong growth in Revenue. The Revenue will grow by 8.09% on average per year.
EPS Next Y54.21%
EPS Next 2Y16.51%
EPS Next 3Y16.11%
EPS Next 5YN/A
Revenue Next Year8.58%
Revenue Next 2Y7.81%
Revenue Next 3Y8.09%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EUZ.DE Yearly Revenue VS EstimatesEUZ.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EUZ.DE Yearly EPS VS EstimatesEUZ.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.71 indicates a rather expensive valuation of EUZ.
Based on the Price/Earnings ratio, EUZ is valued a bit cheaper than 72.31% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.00, EUZ is valued at the same level.
Based on the Price/Forward Earnings ratio of 18.33, the valuation of EUZ can be described as rather expensive.
Based on the Price/Forward Earnings ratio, EUZ is valued a bit cheaper than 67.69% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.70. EUZ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.71
Fwd PE 18.33
EUZ.DE Price Earnings VS Forward Price EarningsEUZ.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EUZ indicates a rather cheap valuation: EUZ is cheaper than 84.62% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EUZ indicates a somewhat cheap valuation: EUZ is cheaper than 75.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.11
EV/EBITDA 10.84
EUZ.DE Per share dataEUZ.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EUZ may justify a higher PE ratio.
A more expensive valuation may be justified as EUZ's earnings are expected to grow with 16.11% in the coming years.
PEG (NY)0.44
PEG (5Y)2.74
EPS Next 2Y16.51%
EPS Next 3Y16.11%

3

5. Dividend

5.1 Amount

EUZ has a Yearly Dividend Yield of 1.09%.
Compared to an average industry Dividend Yield of 0.98, EUZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, EUZ's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

The dividend of EUZ decreases each year by -43.97%.
Dividend Growth(5Y)-43.97%
Div Incr Years1
Div Non Decr Years3
EUZ.DE Yearly Dividends per shareEUZ.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

EUZ pays out 26.23% of its income as dividend. This is a sustainable payout ratio.
DP26.23%
EPS Next 2Y16.51%
EPS Next 3Y16.11%
EUZ.DE Yearly Income VS Free CF VS DividendEUZ.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EUZ.DE Dividend Payout.EUZ.DE Dividend Payout, showing the Payout Ratio.EUZ.DE Dividend Payout.PayoutRetained Earnings

ECKERT & ZIEGLER SE

FRA:EUZ (1/8/2026, 7:00:00 PM)

15.41

-0.38 (-2.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13
Earnings (Next)03-26 2026-03-26
Inst Owners30.9%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap978.84M
Revenue(TTM)304.47M
Net Income(TTM)39.75M
Analysts82.86
Price Target21.73 (41.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend0.02
Dividend Growth(5Y)-43.97%
DP26.23%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.19%
PT rev (3m)-5.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.97%
EPS NY rev (3m)18.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 23.71
Fwd PE 18.33
P/S 3.21
P/FCF 22.11
P/OCF 14.72
P/B 4.23
P/tB 5.26
EV/EBITDA 10.84
EPS(TTM)0.65
EY4.22%
EPS(NY)0.84
Fwd EY5.46%
FCF(TTM)0.7
FCFY4.52%
OCF(TTM)1.05
OCFY6.79%
SpS4.79
BVpS3.65
TBVpS2.93
PEG (NY)0.44
PEG (5Y)2.74
Graham Number7.3
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 17.17%
ROCE 17.57%
ROIC 12.48%
ROICexc 18.59%
ROICexgc 22.77%
OM 21.27%
PM (TTM) 13.06%
GM 47.25%
FCFM 14.54%
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexgc growth 3Y11.22%
ROICexgc growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.05
Debt/EBITDA 0.43
Cap/Depr 106.5%
Cap/Sales 7.3%
Interest Coverage 85.33
Cash Conversion 77.65%
Profit Quality 111.36%
Current Ratio 2.93
Quick Ratio 2.37
Altman-Z 4.76
F-Score7
WACC6.98%
ROIC/WACC1.79
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)43.67%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%68.5%
EPS Next Y54.21%
EPS Next 2Y16.51%
EPS Next 3Y16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)9.64%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%7.42%
Revenue Next Year8.58%
Revenue Next 2Y7.81%
Revenue Next 3Y8.09%
Revenue Next 5YN/A
EBIT growth 1Y7.47%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year46.97%
EBIT Next 3Y20.11%
EBIT Next 5YN/A
FCF growth 1Y300.82%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y52.85%
OCF growth 3Y25.28%
OCF growth 5Y10.49%

ECKERT & ZIEGLER SE / EUZ.DE FAQ

What is the fundamental rating for EUZ stock?

ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE.


Can you provide the valuation status for ECKERT & ZIEGLER SE?

ChartMill assigns a valuation rating of 6 / 10 to ECKERT & ZIEGLER SE (EUZ.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EUZ stock?

The Price/Earnings (PE) ratio for ECKERT & ZIEGLER SE (EUZ.DE) is 23.71 and the Price/Book (PB) ratio is 4.23.


Can you provide the dividend sustainability for EUZ stock?

The dividend rating of ECKERT & ZIEGLER SE (EUZ.DE) is 3 / 10 and the dividend payout ratio is 26.23%.